Sheng-yen Hsiao

Tainan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Peripheral T-Cell Lymphomas in Southern Taiwan: Epidemiology, Treatment Patterns, and Long-Term Outcomes.

Peripheral T-Cell Lymphomas in Southern Taiwan: Epidemiology, Treatment Patterns, and Long-Term Outcomes.

Journal: EJHaem
Published: December 11, 2025

Efficacy and safety of trastuzumab deruxtecan in HER2-high and HER2-low breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Efficacy and safety of trastuzumab deruxtecan in HER2-high and HER2-low breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Journal: Journal of chemotherapy (Florence, Italy)
Published: December 04, 2025

A Novel Partial EMT-Associated Transcriptomic Signature for Prognostic Stratification in Ovarian Cancer.

A Novel Partial EMT-Associated Transcriptomic Signature for Prognostic Stratification in Ovarian Cancer.

Journal: Oncology research
Published: October 10, 2025

IL-6 as a driver of bone invasion in IFIT2-depleted oral squamous cell carcinoma.

IL-6 as a driver of bone invasion in IFIT2-depleted oral squamous cell carcinoma.

Journal: Cancer immunology, immunotherapy : CII
Published: July 08, 2025

Unraveling Cathepsin S regulation in interleukin-7-mediated anti-tumor immunity reveals its targeting potential against oral cancer.

Unraveling Cathepsin S regulation in interleukin-7-mediated anti-tumor immunity reveals its targeting potential against oral cancer.

Journal: Journal of biomedical science
Published: February 19, 2025

Frequent association of malignant effusions in plasmablastic lymphoma: a single-institutional experience of nine cases in Taiwan.

Frequent association of malignant effusions in plasmablastic lymphoma: a single-institutional experience of nine cases in Taiwan.

Journal: Blood research
Published: February 07, 2025

Risk assessment of venetoclax-associated adverse events: a meta-analysis approach.

Risk assessment of venetoclax-associated adverse events: a meta-analysis approach.

Journal: Expert opinion on drug safety
Published: January 20, 2025

Treatment outcomes and safety of reduced‑dose venetoclax plus antifungal agents to treat acute myeloid leukemia: A single hospital experience in Taiwan.

Treatment outcomes and safety of reduced‑dose venetoclax plus antifungal agents to treat acute myeloid leukemia: A single hospital experience in Taiwan.

Journal: Oncology letters
Published: November 08, 2024

Efficacy and safety of second‑generation FLT3 inhibitors in acute myeloid leukemia: A systematic review and meta‑analysis of randomized controlled trials.

Efficacy and safety of second‑generation FLT3 inhibitors in acute myeloid leukemia: A systematic review and meta‑analysis of randomized controlled trials.

Journal: Molecular and clinical oncology
Published: June 07, 2024

Melatonin prevents pulmonary fibrosis caused by PM2.5 exposure by targeting epithelial-mesenchymal transition.

Melatonin prevents pulmonary fibrosis caused by PM2.5 exposure by targeting epithelial-mesenchymal transition.

Journal: Toxicology and applied pharmacology
Published: December 05, 2023

Glofitamab as a salvage treatment for B-cell lymphomas in the real world: A multicenter study in Taiwan.

Glofitamab as a salvage treatment for B-cell lymphomas in the real world: A multicenter study in Taiwan.

Journal: Cancer
Published: September 26, 2023

Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer.

Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer.

Journal: PloS one
Published: June 13, 2023
Showing 1-12 of 27

Last Updated: 09/26/2026